Basic characteristics of stable patients with immune mediated polyneuropathies
| Demographic variables and tests | |
|---|---|
| Values are mean (SD) and range unless stated otherwise. | |
| *Five patients could not fulfil the nine hole peg test. | |
| †Seven patients were unable to walk. | |
| CIDP, chronic inflammatory demyelinating polyneuropathy; INCAT, inflammatory neuropathy cause and treatment group; MGUSP, polyneuropathy associated with a monoclonal gammopathy of undetermined significance; MRC, Medical Research Council. | |
| Number of patients | 113 |
| Guillain–Barré syndrome (n) | 83 |
| CIDP (n) | 22 |
| MGUSP (n) | 8 |
| Age at entry (years) | 54.3 (15.1), 14 to 84 |
| Duration of symptoms to onset of study (years) | 6.9 (3.1), 0.5 to 28 |
| Sex distribution (n (%)) | |
| Male | 59 (52) |
| Female | 54 (48) |
| Fatigue severity scale score at entry | 5.6 (1.4), 1 to 7 |
| MRC sum score at entry | 53.3 (7.7), 16 to 60 |
| INCAT sensory sum score at entry | 4.4 (4.1), 0 to 15 |
| Grip strength values with the Vigorimeter at entry (kPa) | |
| Right hand | 66.9 (33.6), 0 to 156 |
| Left hand | 64.9 (32.9), 0 to 158 |
| Overall disability sum score at entry | 3.5 (2.2), 0 to 11 |
| f Score at entry | 1.8 (0.9), 1 to 4 |
| Rankin score at entry | 2.1 (0.9), 0 to 4 |
| Nine hole peg test at entry (s)* | |
| Right hand | 31 (20), 15 to 135 |
| Left hand | 33 (25), 16 to 192 |
| Ten metre walking test at entry (s)† | 10.4 (5.8), 5 to 32 |
| Rotterdam nine item handicap scale at entry | 29.5 (6), 14 to 36 |